investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Scott H Kaufmann

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

William Earnshaw

University of Edinburgh

Edinburgh, United Kingdom

Scott H Kaufmann

Mayo Clinic (Rochester)

Rochester, United States

Related projects

James L M Ferrara

Cellular and Molecular Studies of Bone Marrow Transplant

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Keisuke Nagao

Exploring Mechanisms that Govern Immune Homeostasis in Skin

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Rosemary Rochford

Effects of Malaria on EBV Persistence in Children

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Satish Gopal

Molecular profiling of HIV-associated lymphoma in the US and Malawi

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Satish Gopal

Developing a Clinical Cohort of Histopathologically Characterized Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

George Sachs

The role of ArsS in gastric infection by Helicobacter pylori

Non-Hodgkin lymphoma

Pathology

Scott H Kaufmann

Regulation of Death Ligand-Induced Killing

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology